Table 1.
Patient characteristics (n = 35).
| Characteristics | Total (n) | |
|---|---|---|
| GENDER | ||
| Male | 22 | |
| Female | 13 | |
| AGE | ||
| Median (range) | 64 (40–80) | |
| ECOG | ||
| No | 22 | |
| Yes | 13 | |
| LOCATION | ||
| Head | 10 | |
| Body and tail | 25 | |
| TUMOR SIZE (CM) | ||
| Median (range) | 3.7 (2.0–7.5) | |
| DIFFERENTIATION | ||
| Moderately | 9 | |
| Poorly | 26 | |
| CA19-9 BASELINE | ||
| Median (range) | 2195 (5–30900) | |
| ≤100 | 9 | |
| >100 | 26 | |
| CEA BASELINE | ||
| Median (range) | 9.4 (1.7–241.9) | |
| ≤5 | 12 | |
| >5 | 23 | |
| TIME-TO-PROGRESSION | ||
| Median (range) | 192 (5–423) | |
| SURVIVAL | ||
| Median (range) | 123 (22–660) | |
| FOLLOW-UP DURATION | ||
| Median (range) | 96 (5–660) | |